Funding round
PharmEasy Series E
PharmEasy, which works in digital healthcare platform services in Mumbai, raised $350M in a Series E round announced on 7 Apr 2021, led by Prosus Ventures and TPG, at a $1.50B post-money valuation. 7 firms took part. It is PharmEasy's fifth venture round on record; the one before was a Growth in Nov 2019.
$350M
Amount raised
$1.50B
Post-money valuation
7
Investors
2 leads
23%
Stake sold
new money over the post-money
Valuation
What this round says about the price
This round priced PharmEasy at $1.50B after the new money. The $350M bought investors about 23% of the company. It came 17 months after PharmEasy's Growth. It is 41% of the $858M PharmEasy has raised in the venture rounds on record. PharmEasy raised again 36 months later: a Growth round of $216M in Apr 2024, at $710M post-money.
PharmEasy's funding rounds
PharmEasy has 6 venture rounds on record and 2 other deals. This one is highlighted.
- Series A 1 Jan 2016, led by Bessemer Venture Partners $5.0M
- Series B 3 Apr 2017, led by Bessemer Venture Partners and Orios Venture Partners $17M
- Series C 26 Sep 2018, led by Eight Roads $50M
- Debt not a venture round 27 Sep 2018 $5.5M
- Growth 27 Nov 2019 $220M
- Series E this round 7 Apr 2021, led by Prosus Ventures and TPG $350M$1.50B post-money
- Growth 30 Apr 2024, led by Manipal Education and Medical Group $216M$710M post-money
- Debt not a venture round 1 Sep 2025, led by 360 One $193M
Investors
Who put money in
Prosus Ventures and TPG led the round with 5 other firms.
Lead investors
- Prosus Ventures new investor
- TPG backs 114 venture-backed companies new investor
Use of proceeds
What the money is for
According to the announcement, the money goes to geographic expansion, sales and marketing and scaling operations.
- Geographic expansion
- Sales and marketing
- Scaling operations
Comparable rounds
How it compares
The closest in time: 2 in Drug Stores & Pharmacies, then Series E rounds in any sector within 6 months:
| Company | Announced | Amount | Post-money | Led by |
|---|---|---|---|---|
| Alto Pharmacy Drug Stores & Pharmacies | 27 Jan 2022 | $200M | $1.70B | SoftBank Vision Fund and SoftBank |
| Fuze Health Drug Stores & Pharmacies | 27 Jan 2022 | $200M | not disclosed | SoftBank Vision Fund |
| Trax Tech Companies | 7 Apr 2021 | $640M | not disclosed | SoftBank Vision Fund and BlackRock, Inc. |
| Tech Companies | 7 Apr 2021 | $350M | not disclosed | Prosus and TPG |
| Software Development Services | 13 Apr 2021 | $325M | $7.30B | Dragoneer Investment Group and Greenoaks |
| Tech Companies | 15 Apr 2021 | $205M | $1.34B | Owl Rock Capital |
| Tech Companies | 14 Apr 2021 | $200M | $4.00B | Sequoia Capital |
| Razorpay Payment Processing & Point of Sale | 19 Apr 2021 | $160M | $3.00B | Sequoia Capital and GIC |
Sources
Where this comes from
Reported by 5 sources.
Questions
Frequently asked
How much did PharmEasy raise in its Series E round?
PharmEasy raised $350M in its Series E round, announced in Apr 2021.
Who led PharmEasy's Series E round?
Prosus Ventures and TPG led it, with Temasek, La Caisse, Lightrock, Eight Roads and Think Investments.
What was PharmEasy's valuation at the Series E round?
$1.50B post-money.
Did PharmEasy raise again after this round?
Yes: a Growth round in Apr 2024 of $216M at $710M post-money.